Maravai LifeSciences (MRVI) Stock: Buy, Sell, or Hold?
MRVI - Maravai LifeSciences Holdings, Inc. Class A Common Stock
$7.50
-0.16 (-2.09%)
âŧ
5d:
-1.96%
30d:
+2.74%
90d:
+24.17%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When MRVI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MRVI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MRVI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MRVI is currently trading at $7.50, which is considered fair relative to its 30-day fair value range of $6.87 to $8.06.
Technical Outlook: Technically, MRVI is in a strong uptrend. Immediate support is located at $6.83, while resistance sits at $7.76.
Market Sentiment: MRVI scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MRVI is in a strong uptrend. Immediate support is located at $6.83, while resistance sits at $7.76.
Market Sentiment: MRVI scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$6.87 -
$8.06
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (13/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($7.60)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$6.87 -
$8.06
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$6.83
Resistance Level
$7.76
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-76.37
Wall Street Target
$7.60
(+1.3%)
Revenue Growth (YoY)
8.5%
Earnings Growth (YoY)
-32.7%
Profit Margin
-37.1%
Share & Embed Analysis
Last updated: October 02, 2026 2:55 AM ET
Data refreshes hourly during market hours. Next update: 3:55 AM
Data refreshes hourly during market hours. Next update: 3:55 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRVI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 55 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 58 HOLD |
|
IMCR
Immunocore Holdings Ltd |
STRONG BUY
17 analysts |
$63 | 74 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$21 | 52 HOLD |
